Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R MacRae

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Prenatal Diagnosis|July 13, 2006
Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndromeWendy Y Craig, James E Haddow, Glenn E Palomaki, et al.
Current Oncology (Toronto, Ont.)|March 12, 2019
Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancerS A Laurie, S Banerji, N Blais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline UpdateHarold J Burstein, Mark R Somerfield, Debra L Barton, et al.
Breast Cancer Research : BCR|March 8, 2014
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patientsMaryam B Lustberg, Priya Balasubramanian, Brandon Miller, et al.
Cancer Immunology, Immunotherapy : CII|July 9, 2017
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancerRobert Wesolowski, Megan C Duggan, Andrew Stiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2020
Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i> Mutations: Results of the NCI-MATCH Trial Subprotocol HApril K S Salama, Shuli Li, Erin R Macrae, et al.
JCO Precision Oncology|September 14, 2020
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient PerceptionsDaniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, et al.
JCO Precision Oncology|January 14, 2026
Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i><sup><i>V600E</i></sup> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol HApril K S Salama, Victoria Wang, Erin R Macrae, et al.
BMC Cancer|May 8, 2020
Metastatic breast cancer patient perceptions of somatic tumor genomic testingElizabeth J Adams, Sarah Asad, Raquel Reinbolt, et al.
Developmental Cell|May 24, 2017
Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell ProliferationHuayang Liu, James A Dowdle, Safiya Khurshid, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Prenatal Diagnosis|July 13, 2006
Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndromeWendy Y Craig, James E Haddow, Glenn E Palomaki, et al.
Current Oncology (Toronto, Ont.)|March 12, 2019
Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancerS A Laurie, S Banerji, N Blais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline UpdateHarold J Burstein, Mark R Somerfield, Debra L Barton, et al.
Breast Cancer Research : BCR|March 8, 2014
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patientsMaryam B Lustberg, Priya Balasubramanian, Brandon Miller, et al.
Cancer Immunology, Immunotherapy : CII|July 9, 2017
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancerRobert Wesolowski, Megan C Duggan, Andrew Stiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2020
Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i> Mutations: Results of the NCI-MATCH Trial Subprotocol HApril K S Salama, Shuli Li, Erin R Macrae, et al.
JCO Precision Oncology|September 14, 2020
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient PerceptionsDaniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, et al.
JCO Precision Oncology|January 14, 2026
Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i><sup><i>V600E</i></sup> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol HApril K S Salama, Victoria Wang, Erin R Macrae, et al.
BMC Cancer|May 8, 2020
Metastatic breast cancer patient perceptions of somatic tumor genomic testingElizabeth J Adams, Sarah Asad, Raquel Reinbolt, et al.
Developmental Cell|May 24, 2017
Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell ProliferationHuayang Liu, James A Dowdle, Safiya Khurshid, et al.
Pageof 16